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Abstract
Background—Research is needed to understand parental factors influencing human
papillomavirus (HPV) vaccination, particularly in groups with a higher burden of cervical cancer.
Purpose—To determine correlates of HPV vaccination among a sample of low-income parents
of age-eligible daughters (aged 9–17 years) who called the 2-1-1 Helpline. Secondary analyses
describe potential differences in HPV vaccination correlates by Hispanic and black parent groups,
specifically.
Methods—This 2009 cross-sectional feasibility survey of cancer prevention needs was
conducted in Houston at the 2-1-1 Texas/United Way Helpline. In 2012, to examine the
association between parental psychosocial, cognitive, and decisional factors and HPV vaccination
uptake (one or two doses), bivariate and multivariable logistic regression analyses were conducted
for minority parents and for Hispanic and black parent groups, separately.
Results—Lower rates of HPV vaccination uptake were reported among minority daughters of
2-1-1 callers (29% overall) compared with national and Texas rates. In final adjusted analysis,
factors positively associated with HPV vaccination uptake included being offered the vaccination
by a doctor or nurse, belief that the vaccine would prevent cervical cancer, and Hispanic ethnicity.
Secondary analyses detected differences in factors associated with vaccination in Hispanic and
black groups.
Conclusions—Findings indicate low levels of vaccination among 2-1-1 callers. Increased
understanding of determinants of HPV vaccination in low-income minority groups can guide
interventions to increase coverage. Because 2-1-1 informational and referral services networks
reach populations considered medically underserved, 2-1-1 can serve as a community hub for
informing development of and implementing approaches aimed at hard-to-reach groups.
Introduction
In 2012, a total of 12,170 U.S. women are expected to be diagnosed and 4220 deaths are
expected from cervical cancer.1 Compared with non-Hispanic whites (NHWs), Hispanic and
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black women have higher cervical cancer incidence rates (70% and 39% higher than NHWs,
respectively), and higher mortality rates (48% and 100% higher than NHWs,
respectively).2, 3 Vaccination against human papillomavirus (HPV) provides an important
prevention tool to help decrease cervical cancer in medically underserved populations.
Although HPV does not pose a health problem for most people, persistent HPV infection is
the primary cause of cervical cancer. For girls and young women (aged 9–26 years),
recommended HPV vaccination can prevent infection from high-risk types that cause an
estimated 70% of cervical cancers.4, 5
Since HPV vaccination recommendations were established, few studies have examined
parental factors influencing vaccination uptake (one or two doses) among low-income
minority populations. In a 2007 review of HPV vaccine acceptability among U.S. parents,
Brewer and Fazekas6 identified 28 studies and reported that parents found the vaccine
acceptable if (1) they believed it was effective; (2) a physician recommended it; and (3) they
felt that the risk of HPV infection was likely. One study reported predictors of vaccine
acceptability by race and ethnicity, and found no differences.7
In a 2010 review of parents HPV vaccination acceptability, Fernandez et al.8 found parent
populations had low knowledge of HPV, high willingness to vaccinate daughters (70%–
85%), and varying acceptance of the vaccine related to health beliefs and attitudes. The
Fernandez review also highlighted the dearth of studies examining differences in
acceptability of vaccination across racial/ethnic groups.8 Since these reviews, additional
studies conducted in the U.S. have examined racial/ethnic minority parents’ HPV and HPV
vaccination knowledge and awareness,9, 10 attitudes and beliefs regarding HPV
vaccination,9–12 and provider-related recommendations.9, 12
Because 2-1-1 helplines represent a unique opportunity to reach large numbers of medically
underserved people,13 the current study examined parent-level factors associated with
vaccination among a low-income minority population. This study also assessed the
feasibility of partnering with the 2-1-1 Texas/United Way Helpline to conduct a cancer
needs assessment survey of callers. Results from this feasibility study will inform larger
studies, and ultimately, intervention program strategies that could be implemented through a
2-1-1 helpline-based program.
To identify parent-level factors associated with HPV vaccination in groups with a higher
burden of cervical cancer, a survey was conducted of low-income parents of daughters (aged
9–17 years) identified through the Greater Houston Area 2-1-1 Helpline. This helpline
serves primarily socioeconomically and medically vulnerable people seeking information to
help meet basic needs (e.g., assistance with food, medical/prescriptions, utilities, or
shelter).13,14 To understand correlates of HPV vaccination among minority parents, this
study described minority parent-level correlates of HPV vaccination of daughters, and
explored correlates of HPV vaccination by Hispanic and black groups separately.
Methods
The 2-1-1 Helpline Center and Study Participants
This cross-sectional HPV vaccination study was embedded in a larger cancer prevention
pilot study conducted during a 6-week period (September to October 2009). The larger
survey assessed cancer prevention needs of 2-1-1 callers in collaboration with the 2-1-1
Texas/ United Way Helpline. Nationally, 2-1-1 helplines are staffed with professional
information and referral specialists (specialists), trained to respond to callers’ needs using
computerized referral databases of local and affordable health and social services. The
United Way of Greater Houston 2-1-1 serves a 13-county area, and received over 732,500
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calls for help in 2009.14 In addition, many nonprofit and governmental agencies work with
2-1-1 Texas and the United Way to identify services to help their clients.
Standard procedures for 2-1-1 calls were followed, in which all calls randomly come into the
2-1-1 helpline and are answered by the next available specialist, who assesses callers’ needs
and provides community referrals. After completing these standard 2-1-1 procedures, ten
specialists transferred all eligible callers to the designated specialists, depending on their
availability to take the call. Two of the dedicated specialists, trained to implement the study
consent and survey protocols, consented and surveyed callers. This protocol helped to
manage overflow so that callers were not waiting a long time on the phone to answer survey
questions. This protocol ensured that all eligible callers had an equal chance of being
invited, helping to achieve recruitment of a random group of callers.
Callers were eligible if they were aged ≥18 years, spoke English or Spanish, called from
within the targeted service area, were not in distress, and did not call on behalf of another
adult. For this study, additional criteria included having a daughter aged 9–17 years and
being self-identified as Hispanic or black. Responses were entered directly into a web-based
survey, and responses were recorded anonymously. No study incentives were offered for
participation. Parents with girls aged 9–17 years who needed HPV vaccination(s) were
referred to clinics offering vaccination through the Texas Vaccines for Children Program.
The University of Texas Health Science Center at Houston Committee for the Protection of
Human Subjects approved the study protocol and procedures.
Measures
This study’s primary outcome variable was HPV vaccination uptake, defined as having one
or two HPV vaccines. Daughters’ HPV vaccination status was assessed through parent
report. Next, sociodemographic, economic, and psychosocial constructs were assessed. A set
of 26 HPV questions were developed and pretested by the Cancer Prevention and Control
Research Network (CPCRN) workgroup through cognitive interviewing methods,15 and
integrated into the 2-1-1 pilot survey. Hypothesized correlates of HPV vaccine uptake were
identified through existing literature and guided by the integrated theoretic model described
by Fishbein.16
While this study did not propose to test a conceptual model, variable selection was informed
by the conceptual framework of HPV vaccination proposed in the Fernandez review.8 The
framework describes the influence of environmental factors on behavior, with environmental
including personal, organizational and community/society-related factors.8 For the present
study, item analysis was conducted on the 26 items identified. Data analyses were conducted
in 2012. After eliminating items with little variance and those with low item-total
correlations, the scale consisted of 16 items: HPV knowledge and perceptions (five items;
heard of HPV, heard of the vaccine, believes HPV can cause cervical cancer, believes it can
be passed through sexual contact, believes the vaccine is most effective when given before
initiation of sexual activity); social norms (one item; other parents in my community have
their daughters receive the vaccine); barriers/benefits to vaccination (four items; if my
daughter gets the vaccine it may cause future health problems, getting the vaccine may cause
problems getting pregnant later, if my daughter gets the vaccine she may be more likely to
think it’s okay to have sex, your daughter getting the vaccine would be a good idea);
severity/susceptibility (two items; compared to other girls, what are your daughter’s chances
of getting HPV; getting HPV would be a serious problem for your daughter); and vaccine
efficacy (two items; how effective is the vaccine at preventing HPV, how effective is the
vaccine at preventing cervical cancer).
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Provider-related factors included two items (daughter offered the vaccine by doctor or nurse
and discussed the vaccine with daughter’s doctor). The final subset of 16 HPV-related
questions included psychosocial and decisional (parent–provider communication)
constructs. Tables 1–3 include response scales for items.
Data Analyses
Chi-square analyses were used to describe parents’ overall sociodemographic, and HPV-
related psychosocial constructs. In secondary analysis, outcomes were examined by
Hispanic and black parent groups, separately. The primary analysis examined associations
between independent variables and HPV vaccination uptake for all participants combined.
Bivariate analyses with p-value <0.10 was used as the criterion to select variables for
multivariable analyses. Variables selected for the final model were tested for
multicollinearity. Any predictors with low tolerance and high variance inflation factors were
dropped from the model. In multivariable analyses, odds of daughter’s vaccination were
estimated using a stepwise logistic regression, adjusted by factors significantly associated
with HPV vaccination initiation in unadjusted analyses (p-value <0.10) after ruling out
multicollinearity.
A secondary analysis described correlates of HPV vaccine uptake separately for Hispanics
and black parents. Bivariate analyses with p-value <0.10 was used to select variables for the
multivariable model and multivariable analyses for each group (Hispanic and black parents).
All data analyses were conducted using SPSS 19.
Results
A total of 99 parent participants reported having a daughter aged 9–17 years living at home
with them, 90% of whom reported their race/ethnicity. The majority of parents identified as
Hispanic or black (47% and 43%, respectively), only 3.4% reported non-Hispanic white
ethnicity, and 7% identified as Other. Most parents participating were women (n=73; 91%),
and 43% of parents reported having no health insurance.
Among the Hispanic parents, 45% completed the survey in Spanish. Overall, 29% of girls
had received at least one HPV vaccination, 31% (n=13) of Hispanic and 26% (n=10) of
black preadolescent/ adolescent daughters. This difference was not significant (x2(1)=0.209,
p=0.65). Only 7.5% of girls received all three doses (n=2 in the black sample; n=4 in the
Hispanic sample).
Correlates of Human Papillomavirus Vaccination Among All Parents
Overall, among all parents, eight factors were positively associated with daughter’s HPV
vaccination status in unadjusted bivariate analyses (p<0.10): heard of HPV, heard of HPV
vaccine, belief that the vaccine will prevent cervical cancer, belief that the vaccine was most
effective before onset of sexual activity, belief that having daughter vaccinated would be a
good idea, compared to other girls daughter has more chance/about the same chance of
getting HPV, whether they had discussed the vaccine with daughter’s doctor, and whether a
doctor or nurse offered the vaccine. Belief that the vaccine may cause future health problems
was negatively associated with vaccination in adjusted analysis (Table 1).
Due to multicollinearity, two variables were dropped: belief that having daughter vaccinated
would be a good idea and belief that the HPV vaccine may cause future health problems.
The following variables were statistically and positively associated with vaccination uptake
in multivariable analysis: being offered the vaccination by a doctor or nurse, belief that the
vaccine would prevent cervical cancer, and Hispanic ethnicity (Table 2).
Savas et al. Page 4










Human Papillomavirus Vaccination Correlates by Hispanic and Black Parent Groups
Within the Hispanic group, four factors were positively associated with daughter’s
vaccination status in unadjusted bivariate analyses (p<0.10): heard of HPV vaccine, belief
that the vaccine was most effective before onset of sexual activity, having discussed the
vaccine with their daughter’s doctor, and having been offered the vaccine by a doctor or
nurse. However, in the fully adjusted model, whether a daughter was offered the HPV
vaccine by a doctor or nurse was the only significant determinant of daughter’s vaccination
status (Table 3).
Within the black group, four factors were positively associated with daughter’s vaccination
status in unadjusted bivariate analyses (p<0.10): perceived efficacy that the vaccine would
prevent cervical cancer, perceived susceptibility of daughter getting HPV compared with
other girls, whether they had discussed the vaccine with their daughter’s doctor, and whether
they had been offered the vaccine by a doctor or nurse. Belief that getting the vaccine might
cause future health problems for their daughter was negatively associated with daughters’
uptake of HPV vaccine. Due to high multicollinearity, belief that HPV prevents cervical
cancer was dropped. In the fully adjusted model for black parents, discussing the vaccine
with their daughters’ doctors was a significant and positive determinant, while belief that the
vaccine could cause future health problems was a significant and negative determinant of
daughter’s vaccination uptake (Table 3).
Discussion
Human papillomavirus vaccination uptake rates overall (29%), and among Hispanic (31%)
and black (26%) girls, were similar to HPV vaccination uptake rates among Hispanic (33%)
and black girls (24%) reported in a Los Angeles–based study conducted in a low-income
minority population.10 In the current final adjusted multivariable analysis, Hispanic
ethnicity, provider recommendation, and perceived efficacy of the vaccine to prevent cancer
all increased the odds of daughters’ vaccination. Among Hispanic parents, having a health
provider offer the vaccine was the only correlate of HPV vaccination. Among black parents,
discussing the HPV vaccine with their daughters’ doctor increased the odds of vaccination,
while belief that the vaccine may cause future health problems decreased vaccination odds.
In the current study, the association found between a healthcare provider’s recommendation
and uptake of HPV vaccination may have important implications for future interventions.
For example, while 74% of Hispanic and 64% of black parents reported they would have
their daughter vaccinated if a doctor recommended it, only 31% of Hispanic and 40% of
black parents reported a health provider recommendation. In addition, lower proportions of
Hispanics (26%) than blacks (42%) reported discussing the HPV vaccine with their
daughter’s provider.
The potential influence of healthcare providers highlights an opportunity to increase
vaccination rates in underserved populations through recommendations delivered by
alternative sources, such as information and referral specialists at 2-1-1 helplines. This type
of innovative approach could help reduce barriers to receiving recommendations and
increase use of preventive services. Larger studies are needed to corroborate the current
findings.
The current findings are similar to previous research that examined factors associated with
daughters’ HPV vaccine uptake in minority populations.9, 10, 12 Bastani et al.10 also reported
parent awareness (having heard of HPV) as a correlate of HPV vaccine uptake. Reiter et
al.12 examined minority parental factors associated with HPV vaccination initiation, and
similar to the current findings, reported that perceived harm of the vaccine was negatively
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associated with vaccination initation.12 While the Reiter study found that among the black
subgroup, daughters had a higher odds of initiating the HPV vaccine if the doctor
recommended it (versus not recommending), this finding differs slightly from the current
finding, in which discussion of vaccination with a doctor, rather than recommendation, was
positively associated with HPV vaccination initiation.
Study strengths include a demonstration of the feasibility of using 2-1-1 helplines to
understand the health needs of hard-to-reach, low-resource, and medically underserved
minority populations. The collaborative effort with the Greater Houston 2-1-1 Helpline
provided access to a socioeconomically disadvantaged population and enabled in-depth
examination of their HPV vaccination behaviors. Moreover, implementation of this
telephone-based survey to both English and Spanish speakers increased access to hard-to-
reach low-literate and Spanish-speaking-only populations. Future studies, including
prospective studies, in larger low-income Hispanic and black populations are needed to
further understand potential culturally or economically mediated barriers and facilitators that
influence HPV vaccination.
Limitations of the study include self-report measures, study design and small sample size,
which limit generalizability. Because it is a cross-sectional study, no causality of
associations may be inferred. Greater statistical power would have increased the ability to
detect differences between constructs and HPV vaccination outcomes, and differences
between the two minority groups. A known limitation of using self-report measures is the
possibility of socially desirable answering. An effort was made to control for this by
ensuring anonymity, and participation did not require follow-up information to be obtained
from callers.
Due to the inherent nature of calls, the low participation rate was an expected limitation.
Many callers needed to address pressing problems and had limited time to participate in the
survey (e.g., were on lunch break or with children). No examination was made of
information on daughter age-specific barriers to vaccination decision-making due to the
small sample. However, understanding differences by age of daughter would be important as
prior studies have shown greater reluctance by parents to vaccinate younger daughters.17, 18
Finally, it was not possible to examine completion of the three-dose vaccine series as an
outcome due to low vaccination uptake in this population. Both initiation and completion
outcomes are important. The uptake of at least one dose is important to understand issues of
vaccination acceptance and barriers, for example. Larger studies are needed to understand
the various predictors of completion of the three-dose series.
This survey served as a feasibility study to understand potential for future collaborations
with the 2-1-1 helpline. In a 6-week period, 375 participants were reached and surveyed, 80
of whom were Hispanic and black parents of adolescent daughters. Based on ability to
integrate this cancer risk assessment survey into 2-1-1-calls, this work has been built on to
conduct a 2-1-1 information and referral specialist–delivered cancer prevention project
consisting of a risk assessment and referrals for affordable prevention services across
multiple behaviors (e.g., mammography, colorectal cancer screening, Pap, and HPV
vaccination).
Ultimately, given the high volume of 2-1-1 callers with self-identified basic needs, a cancer
prevention program integrated into the Greater Houston 2-1-1 Helpline system has the
potential to deliver health prevention messages and support to help connect large numbers of
medically underserved callers to cancer prevention services. The collaborative effort targets
vulnerable groups who have increased barriers to primary health care (e.g., lack of health
insurance)19, and consequently less opportunity to receive doctors’ recommendations for
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preventive screenings or vaccination. This collaborative effort between public health
researchers and the Greater Houston 2-1-1 Helpline system demonstrates a potential to be
replicated in other 2-1-1’s across Texas and nationally.
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Table 1
Significant Bivariate Predictors of Parent-Level Factors Related to Daughters’ HPV Vaccination Uptake, n=80
Bivariate factors 2-1-1 callers
p-value OR (95% CI)
Awareness
  Heard of HPV vaccine or Guardasil, a Yes 0.02** 12.30 (1.48, 102.30)
  Heard of HPV,a Yes 0.05** 3.68 (0.97, 13.97)
Knowledge
  Believes HPV vaccine is most effective when given, b … Before a girl initiates sexual activity 0.07* 2.48 (0.90, 6.83)
Perceived efficacy of the HPV vaccine
  Effectiveness of the HPV vaccine at preventing cervical cancer, c Effective 0.007*** 7.21 (1.72, 30.21)
Perceived susceptibility
  Compared to other girls, your daughter’s chances of getting HPV,d 0.07† 2.66 (0.91, 7.73)
  More/about the same risk as other girls
Barriers/benefits
  The HPV vaccine may cause future health problems,e agree 0.08† 0.29 (0.07, 1.60)
  Your daughter getting the HPV vaccine would be a good idea, e Agree 0.04** 1.20 (1.41, 1.98)
Provider communication
  Discussed the HPV vaccine with daughter’s doctor, a Yes 0.001**** 25.81 (6.16, 108.25)
Provider recommendation












0=after a girl starts having sex/doesn’t matter; 1=before a girl starts having sex
c
0=Not effective; 1=Effective/somewhat effective.
d
0=less chance than other girls; 1=more chance/same chance as other girls
e
0=disagree/don’t know; 1=agree
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Table 2
Multivariable model of parent-level factors related to daughters’ HPV vaccination uptake
Multivariable factors Hispanic/black 2-1-1 callers
Multivariable adjusted model p-value OR (95% CI)
Ethnicity
    Hispanic a 0.05* 5.56 (1.01, 30.66)
Provider recommendation
    Doctor or nurse offered HPV vaccine,b Yes 0.000*** 84.94 (8.74, 825.43)
Perceived efficacy of the HPV vaccine












0=Not effective; 1=Effective/somewhat effective.
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Table 3
Hispanic and black parent-level factors related to daughters’ HPV vaccination uptake
Bivariate factors
Hispanic (n=42) Black (n=38)
p-value OR (95% CI) p-value OR (95% CI)
Awareness
    Heard of HPV vaccine or Guardasil,a Yes 0.04** 9. 43 (1.06, 84.04) ns —
Knowledge
    Believes HPV vaccine is most effective when given, b … Before a
girl initiates sexual activity
0.10* 3.33 (0.81, 13.67) ns —
Perceived HPV vaccine efficacy
    Effectiveness of the HPV vaccine at preventing cervical cancer, c
Effective
ns — 0.002*** 19.50 (2.87, 32.41)
Perceived susceptibility
    Compared to other girls, your daughter’s chances of getting
HPV,d
ns — 0.03** 5.83 (1.20, 28.37)
    More/about the same risk as other girls
Barriers
    The HPV vaccine may cause future health problems, e Agree ns — 0.04** 0.10 (0.01, 0.87)
Provider communication
    Discussed the HPV vaccine with daughter’s doctor, a Yes 0.001**** 25.00 (3.84–162.99) 0.004*** 27.00 (2.89, 52.62)
Provider recommendation
    Doctor or nurse offered HPV vaccine, a Yes 0.000**** 62.50 (7.71–506.66) 0.006*** 12.00 (2.04, 70.45)
Multivariable adjusted model
Hispanic (n=42) Black (n=38)
p-value OR (95% CI) p-value OR (95% CI)
Provider recommendation
    Doctor or nurse offered HPV vaccine, a Yes 0.000**** 110.00 (8.90, 359.17) ns
Provider communication
    Discussed the HPV vaccine with daughter’s doctor, a Yes ns — 0.01*** 30.36 (2.80, 328.60)
Barriers























0=after a girl starts having sex/doesn’t matter; 1=before a girl starts having sex
c
0=Not effective; 1=Effective/somewhat effective.
d
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